Master AI-Enabled Machine Learning Frameworks for Predictive Biomarker Identification in 6 weeks through hands-on, project-based online training with DSTC.
Biomarkers play a critical role in modern healthcare, enabling early disease detection, patient stratification, and personalized treatment strategies. With the rise of high-throughput technologies such as genomics, transcriptomics, proteomics, and clinical datasets, identifying reliable biomarkers requires advanced computational approaches. Traditional statistical methods often fall short when dealing with high-dimensional data, making machine learning (ML) essential for extracting meaningful patterns. Every participant receives a verified e-Certificate and e-Marksheet from the Deep Science & Technology Consortium.
Biomarkers play a critical role in modern healthcare, enabling early disease detection, patient stratification, and personalized treatment strategies. With the rise of high-throughput technologies such as genomics, transcriptomics, proteomics, and clinical datasets, identifying reliable biomarkers requires advanced computational approaches. Traditional statistical methods often fall short when dealing with high-dimensional data, making machine learning (ML) essential for extracting meaningful patterns.
1. Translate biotechnology theory into practical, reproducible analysis.
2. Build a defensible project you can showcase to supervisors, reviewers, or employers.
β’ Master's and senior undergraduate students specializing in biotechnology
β’ R&D engineers and working professionals applying biotechnology in industry
β’ Academics and educators building research or teaching capacity in biotechnology
β’ A demonstrable biotechnology project for your research or industry portfolio.
β’ A verified e-Certificate of competency and e-Marksheet from the Deep Science & Technology Consortium.
β’ Prognostic, predictive, diagnostic and pharmacodynamic biomarkers distinguished
β’ BEST framework terminology and the context of use that governs validation
β’ Intended clinical decision defined before any data analysis begins
β’ Genomic, transcriptomic, proteomic and clinical data combined in one matrix
β’ Missingness that is not at random, and imputation that hides it
β’ Batch and site effects confounded with outcome β the classic false discovery
β’ Univariate filters, LASSO and elastic net, and stability selection over resamples
β’ Correlated features and the instability of any single selected panel
β’ Nested cross-validation as the only unbiased estimate of performance
β’ Discrimination with AUC against calibration, which is more often reported badly
β’ Decision curve analysis and net benefit over the existing standard of care
β’ Class imbalance and why accuracy is meaningless for a rare outcome
β’ Internal, temporal and external validation and what each actually demonstrates
β’ TRIPOD+AI and REMARK reporting checklists
β’ Assay reproducibility, cost and turnaround as the real barriers to adoption
| Parameter | Requirement |
|---|---|
| Covered Tool / Platform | Python |
| Covered Tool / Platform | Scikit-learn |
| Covered Tool / Platform | TensorFlow |
| Covered Tool / Platform | Keras |
| Covered Tool / Platform | Pandas |
| Covered Tool / Platform | NumPy |
| Covered Tool / Platform | Matplotlib |
| Covered Tool / Platform | XGBoost |
Based on 0 scholar submissions
No verified reviews published yet. Be the first to share your academic experience.
Your rating will help prospective scholars. Ratings below 3 stars are routed privately to the faculty mentor for immediate response.